WHO Expert Committee on Drug Dependence : thirty-third report.

This report presents the recommendations of a WHO Expert Committee responsible for reviewing information on dependence-producing drugs to assess the need for their international control. The first part of the report contains a summary of the Committee's evaluations of seven substances (dronabin...

Full description

Saved in:
Bibliographic Details
Online Access: Full text (MCPHS users only)
Format: Electronic eBook
Language:English
Published: Geneva : World Health Organization, 2003
Series:Technical report series (World Health Organization) ; 915.
Subjects:
Local Note:ProQuest Ebook Central

MARC

LEADER 00000cam a2200000 a 4500
001 in00000275184
006 m o d
007 cr cn|||||||||
008 040211s2003 sz go 000 0 eng d
005 20240703135751.7
019 |a 54063535  |a 191039474  |a 488487281  |a 614539793  |a 647288505  |a 722204078  |a 728011383  |a 827878575  |a 961650365  |a 962561733  |a 994397383 
020 |a 9240681531 
020 |a 9789240681538 
020 |a 0585492727 
020 |a 9780585492728 
020 |a 9789241209151 
020 |a 9241209151 
020 |z 9241209151 
029 1 |a AU@  |b 000050228569 
029 1 |a AU@  |b 000053029880 
029 1 |a AU@  |b 000062573435 
029 1 |a DEBBG  |b BV044122756 
029 1 |a NZ1  |b 11924168 
029 1 |a NZ1  |b 13660549 
029 1 |a NZ1  |b 13698410 
035 |a (OCoLC)55664162  |z (OCoLC)54063535  |z (OCoLC)191039474  |z (OCoLC)488487281  |z (OCoLC)614539793  |z (OCoLC)647288505  |z (OCoLC)722204078  |z (OCoLC)728011383  |z (OCoLC)827878575  |z (OCoLC)961650365  |z (OCoLC)962561733  |z (OCoLC)994397383 
035 |a (OCoLC)ocm55664162  
040 |a CSL  |b eng  |e pn  |c CSL  |d OCLCQ  |d YDXCP  |d OCLCQ  |d DKDLA  |d ADU  |d E7B  |d MHW  |d FVL  |d OCLCQ  |d MERUC  |d EBLCP  |d OCLCO  |d OCLCQ  |d VLB  |d OCLCF  |d OCLCQ  |d CUS  |d OCLCQ  |d N$T  |d ZMC  |d OCLCQ  |d AZK  |d COCUF  |d MOR  |d Z5A  |d OCLCO  |d PIFBR  |d ZCU  |d XFH  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d OCLCA  |d STF  |d WRM  |d NRAMU  |d ICG  |d VT2  |d OCLCQ  |d CUY  |d OCLCO  |d OCLCA  |d TKN  |d DKC  |d AU@  |d OCLCQ  |d OCLCO  |d M8D  |d UMK  |d OCLCA  |d OCLCO  |d N$T  |d OCLCQ  |d OCL  |d INARC  |d OCLCO 
050 4 |a HV4998  |b .W46 2003eb 
070 |a 449.9  |b W892T no. 915 
072 7 |a SEL  |x 026000  |2 bisacsh 
072 7 |a PSY  |x 038000  |2 bisacsh 
082 0 4 |a 362.29  |2 23/eng/20220628 
245 0 0 |a WHO Expert Committee on Drug Dependence :  |b thirty-third report. 
260 |a Geneva :  |b World Health Organization,  |c 2003. 
300 |a 1 online resource (31 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
490 1 |a WHO technical report series ;  |v 915 
505 0 |a 1. Introduction; 2. Scheduling criteria; 3. Critical review of psychoactive substances; 4. Pre-review of psychoactive substances; 5. Terminology used in reporting abuse-related adverse drug reactions; 6. Other matters; Acknowledgements; References; Annex Terminology used in reporting abuse-related adverse drug reactions; References. 
520 |a This report presents the recommendations of a WHO Expert Committee responsible for reviewing information on dependence-producing drugs to assess the need for their international control. The first part of the report contains a summary of the Committee's evaluations of seven substances (dronabinol, oripavine, buprenorphine, butorphanol, ketamine, khat and zopiclone). The report also discusses the substances that were pre-reviewed (gamma-hydroxybutyric acid and tramadol) and recommended gamma-hydroxybutyric acid for critical review at a future meeting. Two substances (gamma-butyrolactone and 1,4-butanediol) were identified for future pre-review). 
546 |a English. 
588 0 |a Print version record. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Substance abuse. 
650 0 |a Drug abuse. 
650 0 |a Designer drugs. 
650 0 |a Stereoisomers. 
650 0 |a Ephedrine. 
650 0 |a Drug addiction. 
650 0 |a Psychotropic drugs. 
650 2 |a Psychotropic Drugs 
650 2 |a Substance-Related Disorders 
650 2 |a Drug and Narcotic Control 
650 2 |a Catha 
650 2 |a Designer Drugs 
650 2 |a Stereoisomerism 
650 7 |a substance abuse.  |2 aat 
650 7 |a drug addiction.  |2 aat 
650 7 |a drug abuse.  |2 aat 
776 0 8 |i Print version:  |t WHO Expert Committee on Drug Dependence.  |d Geneva : World Health Organization, ©2003  |z 9241209151  |w (OCoLC)52313359 
830 0 |a Technical report series (World Health Organization) ;  |v 915. 
852 |b E-Collections  |h ProQuest 
856 4 0 |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=284791  |z Full text (MCPHS users only)  |t 0 
936 |a BATCHLOAD 
938 |a Internet Archive  |b INAR  |n whoexpertcommitt0000unse_l6u1 
938 |a EBL - Ebook Library  |b EBLB  |n EBL284791 
938 |a ebrary  |b EBRY  |n ebr10047391 
938 |a EBSCOhost  |b EBSC  |n 102432 
938 |a YBP Library Services  |b YANK  |n 2633241 
938 |a YBP Library Services  |b YANK  |n 2337027 
947 |a FLO  |x pq-ebc-base 
999 f f |s 87418c9a-ed77-4752-84c4-d79f119a8935  |i 4aac65ef-f93d-43b9-b055-df8df3cc9fd7  |t 0 
952 f f |a Massachusetts College of Pharmacy and Health Sciences  |b Online  |c Online  |d E-Collections  |t 0  |e ProQuest  |h Other scheme 
856 4 0 |t 0  |u https://ebookcentral.proquest.com/lib/mcphs/detail.action?docID=284791  |y Full text (MCPHS users only)